Client Spotlight: OyaGen Compound Could Help Treat COVID-19

Our senior crisis communications managers have been hard at work supporting numerous clients with their coronavirus messaging needs in recent weeks. Thankfully, some of this work has been in support of good health-related news, including a potential treatment for COVID-19.

Tipping Point recently worked with an agency partner to support Rochester-based biotech firm OyaGen Inc. with its national announcement of a potential coronavirus treatment. The company is working with the National Institute of Allergy and Infectious Diseases on a compound with broad antiviral activity against SAR-CoV-2, the causative agent of COVID-19.

For more information, see:

OyaGen Discovers Compound That Could Help With COVID-19

Local Biotech Company Testing Treatment for COVID-19

Companies Are Getting Close to Coronavirus Treatments, Potential Cure